This year’s program marked the largest in-person advocacy event in the Foundation’s history.
Site Search
Showing 21 - 23 of 23 results
News
|
March 19, 2024
|
3 min read
Since 2011, the Foundation has awarded $2.5 million across 35 different projects to improve cystic fibrosis newborn screening across the country.
News
|
Sept. 28, 2023
|
4 min read
With this approval, approximately 2,250 children in the U.S. will be eligible for Trikafta® (elexacaftor/tezacaftor/ivacaftor), including more than 900 who will have access to a CFTR modulator for the first time. The Cystic Fibrosis Foundation believes it is beneficial to start people with cystic fibrosis on modulators as early as possible to help prevent lung damage and the onset of complications.
News
|
April 26, 2023
|
3 min read